Recent Quotes
My Watchlist
Indicators
Local Stocks
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about DMT Clinical Trial

Recent news which mentions DMT Clinical Trial

Atai's DMT Depression Drug Shows Promise, Prepares For Phase II Trial And Future Collaboration With Pharma Giant
Tickers ATAI
Tags treatment/resistant depression Health Care Psychedelics
From Benzinga
Cybin Inc's Two Deuterated Psychedelic Molecules Achieve Positive Topline Clinical Results
Tickers CYBN NEWS
Tags Benzinga Psychedelic/Assisted Therapies Global
From Benzinga
Cybin Officially Owns Small Pharma: Plans For New 'International Leader' In Psychedelic Therapeutics
Tickers CYBN DMTTF
Tags Psychedelics Psychedelics Research M&A
From Benzinga
Atai Life Sciences Completes Phase 1 Clinical Study Of Oral Film DMT Formulation
Tickers ATAI
Tags treatment/resistant depression Psychedelics Market News
From Benzinga
Cybin And Fluence Partner To Support EMBARK Training For Phase 3 CYB003 Trial For Depression
Tickers CYBN
Tags Global Psychedelic/Assisted Therapies Penny Stocks
From Benzinga
Depression Relief: Possible Therapy Boost With DMT & SSRIs, Per Small Pharma Clinical Results
Tickers CYBN DMTTF
Tags major depressive disorder Psychedelics Market News
From Benzinga
Cybin's Acquisition Of Small Pharma Will Elevate DMT Therapeutics For Depression And Anxiety
Tickers CYBN DMTTF
Tags Guidance Markets DMTTF
From Benzinga
Cybin Launches 3-Day Overnight Public Offering For Up To $8.25M, Suspends Prior Purchase Deal
Tickers CYBN IPOS
Tags CYBN Psychedelics IPOs
From Benzinga
DMT's Clinical Path For Treating TBI And Stroke: Phase 1 Dosing Finished As Phase 2 Gears Up
Tickers AGNPF
Tags AGN Neuro Market News Cannabis
From Benzinga
Novel DMT Compound For Anxiety Shows Clinical Progress: Robust Effects Within 2 Minutes
Tickers CYBN
Tags CYBN Psychedelics DMT Entities
From Benzinga
Atai Life Sciences Q1 2023 Results, Pipeline Update On DMT And Psilocybin Clinical Trials
Tickers ATAI CMPS
Tags Psychedelics Small Cap Benzinga
From Benzinga
This IV Psychedelic-Based Compound Completes Phase 2a Trial, Company Gets Extra IP Coverage
Tickers DMTTF
Tags DMTTF Markets News
From Benzinga
Psychedelic Therapeutics For Human Stroke: Participant Screening Expects To Begin Soon
Tickers AGNPF
Tags Strokes News AGNPF
From Benzinga
Next-Gen Psychedelic Delivers Promising Results For Treatment-Resistant Depression In Phase 2 Clinical Trial
Tickers BMNDF
Tags Benzinga DMT Clinical Trial Penny Stocks
From Benzinga
Tackling Depression With Psychedelics: New Phase 2 Clinical Study Begins At Yale University
Tickers AGNPF
Tags Benzinga Yale University DMT Clinical Trial
From Benzinga
atai's Phase 1 Synthetic DMT-Based Drug Clinical Trial Begins Patient Dosing
Tickers ATAI
Tags Markets Cannabis Market News
From Benzinga
Clinical Study On DMT Inhaled Product For Treatment-Resistant Depression Completes Dosing Stage
Tickers BMNDF
Tags BMNDF News Alejandro Antalich
From Benzinga
A Deeper Look At DMT Trials & Studies
Tickers DMT
Tags Psychedelics Cannabis Markets
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.